Affiliation:
1. Department of Pharmacy
2. Preparation Department, Shijiazhuang Fourth Hospital, Shijiazhuang, Hebei, People’s Republic of China
Abstract
Objective:
Yixishu lotion (YXSL) originates from the summary of traditional Chinese medicine clinical experience and constantly improves in practice in clinical validation of the exact efficacy of traditional Chinese medicine prescription. To explore the mechanism of YXSL in treating vaginitis and the potential mechanisms based on network pharmacology and experimental verification.
Methods:
The active components and drug-related targets of YXSL were retrieved from the TCMSP (Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform) database, and the target was predicted by the UniProt database. Searching for genes related to ‘vaginitis’ disease in the GeneCards database, a total of 2581 drug targets were obtained. The interaction between proteins (PPI – protein–protein interaction) relationship was obtained by STRING database and visualized by Cytoscape software. Finally, the ‘Bioconductor’ installation package in R software was used to analyze the GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways of the target.
Results:
In this study, by the method of network pharmacology, the key active components of YXSL were flavonoids such as quercetin, apigenin, kaempferol, luteolin, β-sitosterol; the main core proteins included MAPK14, TP53, FGF2, ESR1, MAPK3, MAPK1, VEGFA, JUN, IL-6, and the KEGG pathway was mainly involved in MAPK pathway, Th17 pathway, Malaria, TNF pathway, and other signaling pathways. Animal experiments showed that the clinical symptoms and vaginal tissue lesions of the YXSL group and the fluconazole group were improved, and the levels of TNF-α (tumor necrosis factor alpha), IL-6 (interleukin-6), MDA (malondialdehyde), SOD (superoxide dismutase), IL-4, and IFN-γ (interferon-γ) in vaginal tissue and serum were better than the model group.
Conclusion:
YXSL may achieve its therapeutic effect on vaginitis by reducing the inflammatory response, improving oxidative stress response, and improving body immunity, and it provides a theoretical basis for further research on its pharmacodynamic material basis and mechanism of action.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference30 articles.
1. The pathogenic bacteria classification and age distribution of 445 female patients with vaginitis;Zhou;Chin J Hum Sex,2016
2. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines;Ru;J Cheminform,2014
3. Rapid access to biomedical knowledge with GeneCards and HotMolecBase: implications for the electrophoretic analysis of large sets of gene products;Rebhan;Electrophoresis,1997
4. Candida albicans vaginitis in a murine model is reduced by polypeptide-enriched Gastrodia elata extracts;Cai;Future Microbiol,2019
5. The expression of IGFBP7 in Balb/c mouse model of candida vaginitis and its significance;Tan;Chin J Dermatovenereol,2010